Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock;Valor pronóstico del aclaramiento de procalcitonina, PCR y leucocitos en el shock séptico

Medicina Intensiva

Volumn 36, Issue 3, 2012, Pages 177-184

  Suberviola, B ^a   Castellanos Ortega, A ^a   Gonzalez Castro A ^a   Garcia Astudillo L A ^a   Fernandez Miret B ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Biomarkers; Procalcitonin; Sepsis; Septic shock

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; HORMONE METABOLISM; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK;

AGED; AGED, 80 AND OVER; APACHE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMORBIDITY; DIAGNOSIS-RELATED GROUPS; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

EID: 84859163676     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.09.008     Document Type: Article

References (38)

1. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
2. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123.
3. Esteban A., Frutos-Vivar F., Ferguson N.D., Peñuelas O., Lorente J.A., Gordo F., et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35:1284-1289.
4. Nguyen H.B., Corbett S.W., Steele R., Banta J., Clark R.T., Hayes S.R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007, 35:1105-1112.
5. Shapiro N.I., Howell M.D., Talmor D., Lahey D., Ngo L., Buras J., et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34:1025-1032.
6. Trzeciak S., Dellinger R.P., Abate N.L., Cowan R.M., Stauss M., Kilgannon J.H., et al. Translating research to clinical practice. A 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006, 129:225-232.
7. Kortgen A., Niederprum P., Bauer M. Implementation of an evidence-based standard operating procedure and outcome in septic shock. Crit Care Med 2006, 34:943-949.
8. Ferrer R., Artigas A., Levy M.M., Blanco J., González-Díaz G., Garnacho-Montero J., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
9. El Solh A.A., Akinnusi M.E., Alsawalha L.N., Pineda L.A. Outcome of septic shock in older adults after implementation of the sepsis bundle. J Am Geriatr Soc 2008, 56:272-278.
10. Varpula M., Karlsson S., Parviainen I., Ruokonen E., Pettilä V. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 2007, 51:1320-1326. Finnsepsis Study Group.
11. Micek S.T., Roubinian N., Heuring T., Bode M., Williams J., Harrison C., et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006, 34:2707-2713.
12. Castellanos-Ortega A., Suberviola B., García-Astudillo L.A., Holanda M.S., Ortiz F., Llorca J., et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a 3-year follow-up quasi-experimental study. Crit Care Med 2010, 38:1036-1043.
13. Garnacho-Montero J., García-Garmendia J.L., Barrero-Almodovar A., Jiménez-Jiménez F.J., Pérez-Paredes C., Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31:2742-2751.
14. Alberti C., Brun-Buisson C., Goodman S.V., Guidici D., Granton J., Moreno R., et al. European Sepsis Group: Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003, 168:77-84.
15. Cohen J., Brun-Buisson C., Torres A., Jorgensen J. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004, 32:S466-S494.
16. Christ-Crain M., Müller B. Procalcitonin in bacterial infections-hype, hope, more or less?. Swiss Med Wkly 2005, 135:451-460.
17. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36:941-952.
18. Castelli G.P., Pognani C., Cita M., Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37:1845-1849.
19. Becker K.L., Snider R., Nylen E.S. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 2010, 159:253-264.
20. Amour J., Birenbaum A., Langeron O., Le Manach Y., Bertrand M., Coriat P., et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008, 36:1147-1154.
21. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24:680-684.
22. Wanner Ga, Keel M., Steckholzer U., Beier W., Stocker R., Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000, 28:950-957.
23. Stiletto R.J., Baacke M., Gotzen L., Lefering R., Renz H. Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion. Crit Care Med 2001, 29:1690-1693.
24. Charles P.E., Kus E., Aho S., Prin S., Doise J.M., Olsson N.O., et al. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis 2009, 22:49.
25. Charles P.E., Tinel C., Barbar S., Aho S., Prin S., Doise J.M., et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 2009, 13:R38.
26. Suberviola Cañas B., González Castro A., Holanda Peña M.S., Fernández Miret B. Usefulness of procalcitonin in the diagnosis of infection in lung transplant patients. Med Intensiva 2009, 33:358-359.
27. Suberviola Cañas B., González Castro A., Fernández Miret B., Rubio López I., García Astudillo L.A., et al. Procalcitonin: an allied in the management of the patient submitted to abdominal surgery. Rev Esp Enferm Dig 2009, 101:513-514.
28. Boussekey N., Leroy O., Alfandari S., Devos P., Georges H., Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006, 32:469-472.
29. Seligman R., Meisner M., Lisboa T.C., Hertz F.T., Filippin T.B., Fachel J.M., et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006, 10:R125.
30. Meisner M., Adina H., Schtmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006, 10:R1.
31. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huyghens L., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30:757-762.
32. Karlsson S., Heikkinen M., Pettilä V., Alila S., Väisänen S., Pulkki K., et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care Med 2010, 14:R205.
33. Nylen E.S., Whang K.T., Snider R.H., Steinwald P.M., White J.C., Becker K.L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998, 26:1001-1006.
34. Meisner M., Schmitd J., Hüttner H., Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26(Suppl 2):S212-S216.
35. Lam M.F., Leung J.C., Lam C.W., Tse K.C., Lo W.K., Lui S.L., et al. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 2008, 28:377-384.
36. Porcel J.M., Vives M., Cao G., Bielsa S., Ruiz-González A., Martínez-Iribarren A., et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009, 34:1383-1389.
37. Tschaikowsky K., Hedwig-Geissing M., Braun G.G., Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2010, 26:54-64.
38. Ruiz-álvarez M.J., García-Valdecasas S., de Pablo R., Sanchez García M., Coca C., Groeneveld T.W., et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009, 24:63-71.